Retacrit 4000unit Inj, 1ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into the fatty tissue under the skin or into a vein by a healthcare professional.
Self-Administration
If you will be giving yourself injections, your doctor or nurse will provide guidance on the proper technique. It is essential to follow their instructions carefully.
Precautions
Before using this medication, make sure to:
Not shake the container
Not use the medication if it has been shaken
Wash your hands before and after handling the medication
Check the solution for cloudiness, leakage, or particles, and do not use it if you notice any of these issues
Verify that the solution has not changed color
Avoid injecting into skin that is irritated, tender, bruised, red, scaly, hard, scarred, or has stretch marks
Disposal
After use, dispose of needles and other sharp objects in a designated needle/sharp disposal box. Do not reuse needles or other items. When the box is full, follow local regulations for proper disposal. If you have any questions, consult your doctor or pharmacist.
Storage and Disposal
For all products, follow the storage instructions provided. If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- Maintain adequate iron intake, often requiring iron supplements as prescribed by your doctor.
- Monitor your blood pressure regularly as instructed by your healthcare provider.
- Report any new or worsening symptoms promptly to your doctor.
- Do not shake the vial; shaking can damage the medicine.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Signs of high blood pressure: severe headache, dizziness, fainting, or changes in vision.
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath.
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat.
Rapid heartbeat.
Shortness of breath, significant weight gain, or swelling in the arms or legs.
Weakness on one side of the body, difficulty speaking or thinking, balance problems, drooping on one side of the face, or blurred vision.
Confusion.
Cool or pale arm or leg.
Difficulty walking.
Dizziness or fainting.
Excessive sweating.
Seizures.
Extreme fatigue or weakness.
Pale skin.
Depression.
Blood Clots and Severe Skin Reactions
If you experience any of the following symptoms, seek medical help immediately:
Signs of a blood clot: chest pain or pressure, coughing up blood, shortness of breath, swelling, warmth, numbness, color changes, or pain in a leg or arm, or difficulty speaking or swallowing.
Severe skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis): red, swollen, blistered, or peeling skin (with or without fever), red or irritated eyes, or sores in the mouth, throat, nose, or eyes. This condition can cause severe health problems and may be life-threatening.
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or persist, contact your doctor:
Irritation at the injection site.
Fever or chills.
Headache.
Upset stomach or vomiting.
Cough.
Bone, joint, or muscle pain.
Muscle spasms.
Mouth irritation or mouth sores.
Weight loss.
Sleep disturbances.
* Common cold symptoms.
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Chest pain, shortness of breath, or sudden weakness/numbness on one side of the body (signs of heart attack or stroke)
- Sudden severe headache, confusion, or vision changes (signs of stroke or severe hypertension)
- Pain, swelling, warmth, or redness in an arm or leg (signs of a blood clot)
- Signs of an allergic reaction (rash, itching, hives, swelling of the face/lips/tongue/throat, severe dizziness, trouble breathing)
- Unusual tiredness, dizziness, or pale skin (signs of worsening anemia or other issues)
Before Using This Medicine
It is essential to inform your doctor about the following conditions before starting this medication:
Any allergies you have, including allergies to this drug, its components, or other substances, and describe the symptoms you experienced.
If you have high blood pressure.
If you are currently experiencing active bleeding.
If you have low levels of vitamins or minerals.
If you have a condition called Pure Red Cell Aplasia (PRCA), a type of anemia.
Additionally, if you are using a multi-dose container, tell your doctor:
If you are pregnant or think you might be pregnant. This medication is not recommended during pregnancy.
If you are breastfeeding. You should not breastfeed while taking this medication and for 2 weeks after your last dose.
If the patient is a premature baby or newborn. This form of the medication should not be given to premature babies or newborns.
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other drugs and health conditions. Never start, stop, or change the dose of any medication without consulting your doctor first.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Monitoring Your Health
You will need to have your blood pressure checked regularly, as directed by your doctor, because this medication can cause high blood pressure. Additionally, your doctor will instruct you on when to have blood work done to monitor your health.
Special Considerations
If you have phenylketonuria (PKU), consult with your doctor before taking this medication, as some products contain phenylalanine.
Safe Use of Your Medication
Do not exceed the dosage prescribed by your doctor, as taking more than the recommended amount can increase the risk of severe side effects. If you accidentally take more than the prescribed dose, contact your doctor immediately.
Understanding the Effects of Your Medication
This medication can increase the production of red blood cells in your blood. Be aware that misuse or abuse of this type of medication can lead to serious health issues, including stroke, heart attack, and blood clots. If you have any questions or concerns, discuss them with your doctor.
Multi-Dose Container Precautions
This medication contains benzyl alcohol. If possible, avoid using products with benzyl alcohol in newborns or infants, as serious side effects can occur in these children, especially when combined with other medications containing benzyl alcohol. If you have questions, consult with your doctor.
Single-Dose Container Precautions
If you are pregnant, planning to become pregnant, or are breastfeeding, inform your doctor. You and your doctor will need to discuss the potential benefits and risks of this medication to both you and your baby.
Overdose Information
Overdose Symptoms:
- Polycythemia (excessively high red blood cell count), which can lead to increased blood viscosity and risk of thrombotic events (blood clots), stroke, or heart attack.
- Exacerbation of side effects like hypertension.
What to Do:
Management is supportive. If severe polycythemia occurs, phlebotomy (removal of blood) may be considered to reduce blood viscosity. Call 1-800-222-1222 (Poison Control) or seek immediate medical attention.
Drug Interactions
Monitoring
Baseline Monitoring
Rationale: To establish baseline anemia severity and guide initial dosing.
Timing: Prior to initiation of therapy.
Rationale: Adequate iron stores are essential for optimal response to ESAs. Iron deficiency can lead to resistance.
Timing: Prior to and during therapy.
Rationale: Hypertension is a common side effect and can be exacerbated by ESA therapy.
Timing: Prior to initiation and regularly during therapy.
Routine Monitoring
Frequency: Weekly until stable, then every 2-4 weeks.
Target: Individualized, generally 10-11 g/dL. Avoid exceeding 11 g/dL.
Action Threshold: If Hb rises rapidly (>1 g/dL in 2 weeks) or exceeds target, reduce dose. If Hb does not increase or falls, investigate for iron deficiency or other causes of resistance.
Frequency: Regularly (e.g., weekly or bi-weekly initially, then monthly).
Target: Individualized, within patient's normal range.
Action Threshold: If significant increase, manage hypertension aggressively; consider dose reduction or temporary interruption of ESA.
Frequency: Periodically (e.g., every 1-3 months) or as needed.
Target: Ferritin >100 ng/mL, TSAT >20%.
Action Threshold: If iron stores are low, initiate or increase iron supplementation.
Symptom Monitoring
- Symptoms of anemia (fatigue, pallor, shortness of breath)
- Symptoms of hypertension (headache, dizziness, blurred vision)
- Symptoms of thrombotic events (chest pain, shortness of breath, sudden weakness or numbness on one side of the body, vision changes, pain/swelling in a limb)
- Signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
Special Patient Groups
Pregnancy
Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown adverse effects, but there are no adequate and well-controlled studies in pregnant women.
Trimester-Specific Risks:
Lactation
Considered compatible with breastfeeding (L2). Epoetin alfa is a large protein and is poorly excreted into milk. It is also inactivated in the infant's gastrointestinal tract. No adverse effects have been reported in breastfed infants.
Pediatric Use
Dosing is established for pediatric patients with CKD-associated anemia. Safety and efficacy for other indications (e.g., chemotherapy-induced anemia) have not been established in pediatric patients.
Geriatric Use
No specific dose adjustment is required based on age alone. However, older patients may have an increased risk of cardiovascular events and should be monitored closely for hypertension and thrombotic complications.
Clinical Information
Clinical Pearls
- Iron supplementation is almost always required for optimal response to epoetin alfa-epbx, as iron deficiency is a common cause of resistance.
- Do not shake the vial or syringe; shaking can denature the glycoprotein, rendering it inactive.
- Target hemoglobin levels should be individualized and generally kept at the lowest level sufficient to avoid transfusions, typically not exceeding 11 g/dL, due to the increased risk of serious adverse cardiovascular events and stroke.
- Monitor blood pressure closely, as hypertension is a common and potentially serious side effect.
- Educate patients on the signs and symptoms of thrombotic events (e.g., DVT, PE, stroke, MI) and to seek immediate medical attention if they occur.
- Retacrit is a biosimilar to Epogen/Procrit, meaning it is highly similar to and has no clinically meaningful differences from the reference product.
Alternative Therapies
- Other Erythropoiesis-Stimulating Agents (ESAs) such as darbepoetin alfa (Aranesp) or methoxy polyethylene glycol-epoetin beta (Mircera)
- Blood transfusions (for acute, severe anemia or when ESAs are contraindicated/ineffective)
- Iron supplementation (oral or intravenous)
- Treatment of underlying cause of anemia (e.g., nutritional deficiencies, bleeding, inflammatory conditions)